Price target
64.360.00 0.00%
The 23 analysts offering 1 year price forecasts for 38I have a max estimate of — and a min estimate of —.
Analyst rating
Based on 28 analysts giving stock ratings to 38I in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
38I EPS for the last quarter is −1.04 EUR despite the estimation of −1.27 EUR. In the next quarter EPS is expected to reach −1.14 EUR. Track more of INTELLIA THERAPEUTICS INC. financials and stay on top of what is up with the company.
In the next quarter INTELLIA THERAPEUTICS INC. revenue is expected to reach 19.63 M EUR. Check out INTELLIA THERAPEUTICS INC. revenue and earnings and make informed decisions.
According to analysts, 38I price target is 64.36 EUR with a max estimate of 133.56 EUR and a min estimate of 22.26 EUR. Check if this forecast comes true in a year, meanwhile watch INTELLIA THERAPEUTICS INC. stock price chart and keep track of the current situation with 38I news and stock market news.
We've gathered opinions of 28 analysts rating 38I stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.